Decamethonium and serum potassium in man.

Area of Science:

• Anesthesiology
• Pharmacology
• Neurosurgery

Background:

• Depolarizing neuromuscular blocking agents are commonly used in surgery.
• The effect of these agents on serum potassium levels in patients without neuromuscular disease is not fully understood.
• Potential for hyperkalemia exists, especially in specific patient populations.

Purpose of the Study:

• To investigate the impact of depolarizing muscle relaxants on serum potassium levels.
• To compare the effects of decamethonium and succinylcholine on serum potassium.
• To evaluate the implications for patients with pre-existing conditions.

Main Methods:

• A study involving 60 patients undergoing major orthopedic surgery.
• Administration of decamethonium or succinylcholine in standard clinical doses.
• Monitoring of serum potassium (K+) levels before and after drug administration.

Main Results:

• Both decamethonium and succinylcholine caused significant increases in serum potassium.
• The observed hyperkalemia in normal patients is an exaggeration of a normal physiological response.
• Patients with burns, massive trauma, or muscle denervation exhibit accentuated serum potassium elevations.

Conclusions:

• Depolarizing muscle relaxants induce hyperkalemia in patients without neuromuscular disease.
• The risk of severe hyperkalemia is significantly higher in patients with burns, trauma, or denervation.
• Contraindication of depolarizing agents in these high-risk patient groups is recommended.